Quotables
"What, sir, would you make a ship sail against the wind and currents by lighting a bonfire under her deck? I pray you, excuse me, I have not the time to listen to such nonsense."
Napoleon Bonaparte ; When told of the Robert Fulton steamboat
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7365098 | N'-cyano-N-methyl-imidamide derivatives The present invention relates to novel N′-cyano-N-methylimidamide derivatives of the general formula (I) in which n represents 2, 3, 4 or 5, R represents optional... | 04/29/2008 |
| 7214714 | 20-hydroxyeicosatetraenoic acid production inhibitors A hydroxyformamidine compound represented by the following formula or a pharmaceutically acceptable salt thereof [wherein R1 represents a substituted morpholino group, a substituted piperidino group, a... | 05/08/2007 |
| 7048925 | Acid-sensitive polyacetals and methods Polyacetals comprising a recurring units represented by a formula selected from the group consisting of formula (I) and (II): wherein A comprises at least one acetal group; B is selected from t... | 05/23/2006 |
| 7045315 | Methods for modulating expression of exogenous genes in mammalian systems In accordance with the present invention, there are provided various methods for modulating the expression of an exogenous gene in an isolated cell and in a mammalian subject employing modified ecdysone receptors. Also provided are modified ecdysone receptors, as we... | 05/16/2006 |
| 6946485 | Treatment of post-angioplasty restenosis and atherosclerosis with Ras antagonists Disclosed are methods for inhibiting Ras activity such as cell proliferation associated with vascular injury such as post-angioplasty restenosis and atherosclerosis. Preferred Ras antagonists are S-trans-trans farnesylthiosalicylic acid (FTS) and structurally relate... | 09/20/2005 |
| 6878706 | Cyanamides useful as reversible inhibitors of cysteine proteases Compounds according to the following formula (I): wherein the variables Q and R1 to R6 are as described herein, which reversibly inhibit the cysteine proteases, such as cathepsins K, S, F, L and B... | 04/12/2005 |
| 6878374 | Biodegradable polyacetals A polymer comprising recurring units represented by formula (I): wherein X is selected from the group consisting of C(O)OR1, C(O)SR1, C(O)NR1R2, and ... | 04/12/2005 |
| 6806292 | Substituted imide derivatives The present invention relates to novel substituted imide derivatives of the general formula (I) in which R1 represents optionally substituted cycloalkyl, R... | 10/19/2004 |
| 6803375 | Non-peptide inhibition of T-lymphocyte activation and therapies related thereto Compounds, preparations and methods for immunosuppressive treatment of autoimmune disorders, graft rejection and/or graft/host disease. Therapeutically effective amounts of certain substituted triarylmethane compounds, such as 1-[(2-chlorophenyl)diphenylmethyl]-1H-p... | 10/12/2004 |
| 6706761 | Dyed compositions containing insecticides The invention relates to insecticide-comprising polymer-based compositions which, in order to recognize the point in time when the insecticide is exhausted, comprise at least one dye which, after the insecticide has evaporated, turns a different colour. ... | 03/16/2004 |
| 6638979 | Imidamide derivatives The present invention relates to novel imidamide derivatives of the formula (I) ##STR1## in which R, R1, R2 and R3 are each as defined in the description, to a process for their preparation and to their use for control... | 10/28/2003 |
| 6599920 | Naphthalene compounds, intermediates, formulations, and methods This invention relates to the field of pharmaceutical and organic chemistry and provides naphthalene compounds, intermediates, formulations, and methods.... | 07/29/2003 |
| 6555138 | Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances A drug delivery system for oral administration in solid dry form of greasy/oily/sticky substance(s) and pharmaceutically active substance(s) or pharmaceutically active substance(s) which itself/themselves is/are greasy/oily/sticky) characterized by having... | 04/29/2003 |
| 6423748 | Amido polybiguanides and the use thereof as antimicrobial agents Amido polybiguanides and their use as antimicrobial agents in pharmaceutical compositions are disclosed. A method of synthesis of amido polybiguanides is also disclosed. The amido polybiguanides are useful in the preservation of pharmaceutical composition... | 07/23/2002 |
| 6399663 | Highly packed polycationic ammonium, sulfonium and phosphonium lipids The present invention discloses highly packed polycationic ammonium, sulfonium and phosphonium lipid compounds useful for making lipid aggregates for delivery of macromolecules and other compounds into cells. They are especially useful for the DNA-depende... | 06/04/2002 |
| 6262122 | Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl)amino]methyl]amino]benzonitrile The (R)-enantiomer of 4-[[(cyanoimino)-[(1,2,2-trimethylpropyl)amino]methyl]amino]-benzonitrile as well as the corresponding (S)-enantiomer are useful for promoting hair growth such as in male pattern baldness.... | 07/17/2001 |
| 6204294 | IL-8 receptor antagonists This invention relates to novel compounds of Formula (1), pharmaceutical compositions and their use in the treatment of disease states mediated by the chemokine, Interleukins-8 (IL-8).... | 03/20/2001 |
| 6194464 | Imidic acid derivatives and their use as pesticides The present invention relates to new imidic acid derivatives of the formula (I) ##STR1## to a plurality of processes for their preparation, and to their use as pesticides.... | 02/27/2001 |
| 6147098 | Substituted guanidines and diaminonitroethenes, their preparation and use Guanidine and diaminonitroethene derivatives represented by the formula ##STR1## wherein X, R1, R2, R3 and R4 are defined in the description, compositions thereof and methods for preparing the compounds are... | 11/14/2000 |
| 6054411 | Cyanamide aqueous solution Addition of a dicarboxylic acid such as adipic acid to a cyanamide aqueous solution brings about improvement in storage stability of the cyanamide aqueous solution.... | 04/25/2000 |
| 5998442 | Benzo [B] thiophene compounds, and compositions for treating bone loss, and hyperlipidemia The invention provides benzo[b]thiophene compounds, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, and cardiovascular-related pathological conditions including hyperlipidemia and related cardiovascular pat... | 12/07/1999 |
| 5922693 | Cleaning compositions containing biostatic agent The present invention relates to an aqueous cleaning composition containing (a) 1 to 10 weight % of at least one surfactant selected from the group consisting of anionic surfactants and ethoxylated nonionic surfactants and mixtures thereof; (b) 0.2 to 10 weigh... | 07/13/1999 |
| 5594033 | Secoaporphine compound on arrhythmia Novel secoaporphine compounds having the formula I ##STR1## wherein a) R1, R2 and R3, R4 are each methyl group; or b) R1, R2, and R4 are each methyl group; R3 is benzy... | 01/14/1997 |
| 5430059 | Butenoic acid derivatives A butenoic acid compound of the following formula: ##STR1## in which Z is O, S, vinylene or azomethyne, A is an alkylene group and J is phenyl group, is a useful in treating heart disease.... | 07/04/1995 |
| 5382595 | Butenoic or propenoic acid derivative A butenoic or propenoic acid derivative having the following formula in which G is an aryl or a heterocyclic ring, R11 and R12 are hydroben or an alkyl, X is sulfur or oxygen, R2 and R3 are hydrogen, an substituent such as an alkyl and J is pyridyl or phe... | 01/17/1995 |
| 5294616 | Fibrinogen receptor antagonists A series of non-peptide derivatives that are antagonists of the fibrinogen IIb/IIIa receptor and thus are platelet aggregation compounds useful in the prevention and treatment of diseases caused by thrombus formation.... | 03/15/1994 |
| 5262419 | Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator Ulcerative conditions of the gastro-intestinal tract, e.g., antiinflammatory-drug-induced ulcers, are treated or prevented by the administration of a potassium channel activator. Methods and combination products are also disclosed for the treatment of inf... | 11/16/1993 |
| 5087640 | Novel cyanoguanidine derivatives Compounds of the formula: ##STR1## wherein R1 and R2 are independently fluorine, chlorine or bromine atom, and R3 is a C4 -C7 alkyl having at least a branch at the C1 position, exhibit... | 02/11/1992 |
| 5021429 | Pharmacologically active aminoalkylphenyl compounds and their use Compounds of the general formula: ##STR1## and physiologically acceptable salts, and hydrates, N-oxides and bioprecursors of such compounds and such salts in which R1 and R2, which may be the same or different, represent hydrogen ... | 06/04/1991 |
| 5011837 | Aryl cyanoguanidines: potassium channel activators and method of making same Novel compounds of the formula ##STR1## and tautomers thereof, wherein at least one of R2, R3 and R4 is a strong electron withdrawing group, are disclosed. These compounds possess potassium channel activating activity... | 04/30/1991 |
| 5006523 | Antiarrhythmic agents: aryl cyanoguanidine potassium channel blockers Novel compounds of the formula ##STR1## and tautomers thereof are disclosed. These compounds possess potassium channel blocking activity and, as such, are useful as antiarrhythmic agents.... | 04/09/1991 |
| 4943307 | Plant-protective pesticidal composition The invention relates to a plant-protective solution containing 2.5 to 40 % by weight of one or more water-insoluble plant-protective ingredient(s) 20 to 71.5 % by weight of dimethylformamide and/or dimethylsulfoxide and/or acetone as water-miscible solve... | 07/24/1990 |
| 4871756 | Leukotriene antagonists Compounds having the formula: ##STR1## are antagonists of leukotrienes of C4, D4, E4 and the slow reacting substance of anaphylaxis. As such, these compounds will be useful as anti-asthmatic, anti-allergic, anti-infla... | 10/03/1989 |
| 4870056 | Acylated cyanamide composition Acylated cyanamide compounds useful for ethanol deterrence of the formula RCONHCN, wherein R is a lipophilic acyl group or is derived from an (N-substituted)-alpha-aminoacyl group.... | 09/26/1989 |
| 4857550 | Novel insecticidal dibenzoyl-tert-butylcarbazonitrile compounds and method for the preparation thereof The present invention provides novel insecticidal dibenzoyl-tert-butylcarbazonitrile compounds and a method for the preparation thereof. It also provides methods for controlling insects with said dibenzoyl-tert-butylcarbazonitrile compounds and for protec... | 08/15/1989 |
| 4810725 | 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols, pharmaceutical compositions and use 1-Aryloxy-3-(substituted aminoalkylamino)-2-propanols and pharmaceutically acceptable salts thereof have ଲ-adrenergic blocking activity with some cardioselectivity and hence are useful as anti-hypertensive, antianginal, antiarrhythmic and cardioprot... | 03/07/1989 |
| 4782073 | Amides of [(5,6-dichloro-3-oxo-9-alpha-substituted-2,3,9,9-alpha-tetrahydrofluoren -7-yl-oxyl]acetic acids, and pharmaceutical compositions thereof The invention relates to novel amides of [(5,6-dichloro-3-oxo-9a-substituted-2,3,9,9a-tetrahydrofluoren-7-yl)oxy]ac etic acids, their derivatives, and their salts. The compounds are useful for the treatment and prevention of injury to the brain and of edem... | 11/01/1988 |
| 4726941 | Acylated cyanamide composition for treating ethanol ingestion Acylated cyanamide compounds useful for ethanol deterrence of the formula RCONHCN, wherein R is a lipophilic acyl group or is derived from an (N-substituted)-alpha-aminoacyl group.... | 02/23/1988 |
| 4692467 | N'-cyano-n-tetrahydrownaphthyl-s-methyisothiourea as a growth promoting agent This invention relates to novel cyanoguanidine compounds and the intermediate N'-cyano-N-(1,2,3,4-tetrahydro-1-naphthyl)-S-methylisothiourea. These novel compounds are useful as animal growth promoting agents.... | 09/08/1987 |
| 4689348 | Cyanoguanidines useful as animal growth promoting agents This invention relates to novel cyanoguanidine compounds and the intermediate N'-cyano-N-(1,2,3,4-tetrahydro-1-naphthyl)-S-methylisothiourea. These novel compounds are useful as animal growth promoting agents.... | 08/25/1987 |
